Trial Profile
Decrease effects of orexin receptor antagonist Suvorexant on masticatory muscle tone during bruxism or clench measured by portable polysomnography
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Apr 2017
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Bruxism
- Focus Therapeutic Use
- 25 Apr 2017 New trial record